相关实验视频

Updated: Aug 14, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

在高胆固醇贫血小鼠血液中,PI3KC2α抑制具有抗血栓作用

Natasha M Setiabakti1, Volga Tarlac1, Pia Larsson1

  • 1Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

Journal of thrombosis and haemostasis : JTH
|October 12, 2023
PubMed
概括

准PI3-激酶催化子单元2α型 (PI3KC2α) 降低了高胆固醇贫血小鼠的血栓形成. 这表明PI3KC2α抑制是预防高风险患者发生血栓事件的有希望的策略.

关键词:
这就是PI3-酶.这是一种抗血栓的抗血栓药物.过高脂血症是什么意思血小板 血小板 是血栓形成的原因是血栓形成.

更多相关视频

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.1K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...